Businesstimes
Published October 5, 2026
iX Biopharma converts US$1.2 million debt to shares to preserve cash for US expansion
Read the full story at Businesstimes
iX Biopharma's Wafermine is a non-opioid.
Surfaced by this Google Alert
- Ketamine
Live · TradingView